510(k) K022331
K022331 is an FDA 510(k) premarket notification submitted by Bayer Diagnostics Corp. for the device "ADVIA 120 HEMATOLOGY SYSTEM, CEREBROSPINAL FLUID METHOD". The FDA issued a decision of Substantially Equivalent on Sep 11, 2002. The device falls under product code GKL (Counter, Cell, Automated (Particle Counter)), a Class II device regulated under 21 CFR 864.5200. Bayer Diagnostics Corp. has 31 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Sep 11, 2002
- Date Received
- Jul 18, 2002
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Counter, Cell, Automated (Particle Counter)
- Device Class
- Class II
- Regulation Number
- 864.5200
- Review Panel
- HE
- Submission Type
- 510(k)
Need the full FDA record for Bayer Diagnostics Corp.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.